

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1511, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


UK NICE criticised over colorectal cancer guidance
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :


UK NICE criticised over colorectal cancer guidance
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :


Advances in Cancer Therapeutics and Patient Access to New Drugs
PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. :


Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :


Is the UK government delaying approval for new cancer drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. :